Skip to main content
Premium Trial:

Request an Annual Quote

Newcastle University to Use Horizon's X-MAN Models

NEW YORK (GenomeWeb news) – Scientists at Newcastle University will study a panel of Horizon Discovery's mutant and normal X-MAN cancer models for imaging biomarkers that can identify cancer genes within tumors, the university said today.

The goal of the research, which is set to begin this month, is to identify markers that will lead to targeted and personalized drug therapies.

Horizon developed the X-MAN models using its Genesis gene engineering technology.

While recent medical advances have enabled development of targeted therapies for cancer treatment, Newcastle University and Cancer Research UK researcher Herbie Newell said in a statement, "these therapies require tests or biomarkers for effective clinical use in order to match the right drug to the right patient which this collaboration will seek to address."

Financial terms of the agreement were not released.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.